ESSA Pharma Inc
(NAS:EPIX)
$
6.04
-0.01 (-0.17%)
Market Cap: 267.99 Mil
Enterprise Value: 137.64 Mil
PE Ratio: 0
PB Ratio: 2.08
GF Score: 42/100 ESSA Pharma Inc at Jefferies London Healthcare Conference Transcript
Nov 17, 2022 / 03:15PM GMT
Release Date Price:
$3.37
(-8.92%)
Kevin Strang
Jefferies Financial Group Inc. - Analyst
Hi. My name is Kevin Strang. I'm one of the biotech associates here at Jefferies. It's my pleasure today to introduce ESSA Pharma for a fireside chat. I have here with me, David Parkinson, CEO; Peter Virsik, the COO; and David Wood, the CFO. And it's going to be a fireside-chat format. And with that, thank you for joining us today, management.
David Parkinson
ESSA Pharma Inc. - President, CEO & Director
Appreciate the opportunity. Thank you, Kevin.
Kevin Strang
Jefferies Financial Group Inc. - Analyst
And so yeah, we can just dive in if you wouldn't mind telling me, for those who don't know as well, a little bit about ESSA Pharma, and maybe give us a one-minute intro highlighting your main products.
David Parkinson
ESSA Pharma Inc. - President, CEO & Director
Certainly, well ESSA is a small biopharma company focused on small-molecule development to inhibit androgen male hormone biology. That's particularly
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot